From page 13:
"As this Annual Report goes to print the final test report is being completed, and notwithstanding some further challenges posed by the commercial constraints of operating on a unique site, we believe that this program, linked to future projects in India and the Latrobe Valley has demonstrated our strong alignment to the state and federal mandates for lower emissions technology development while balancing energy affordability and reliability.
Further, with each collaboration such as this one comes the ability to explore and develop new opportunities, in line with our core strategic platform, whether that be hydrogen, solid fuel technology, or biomass and biofuels technologies, all of which may provide significant additional and complementary growth prospects"
Is there a reasonable excuse why we aren't being told who the partner for these boiler trials are/were? Why is everything so confidential and held in such secrecy. Even results of this trial with names omitted would be appreciated.
Can anyone tell me why management are so reluctant to let shareholders look at results so as to decide for themselves if the investment is worthwhile?
- Forums
- ASX - By Stock
- ECT
- Ann: Annual Report to shareholders
Ann: Annual Report to shareholders, page-15
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.001(16.7%) |
Mkt cap ! $11.10M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $419 | 127.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
53 | 19761726 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 12532403 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
53 | 19761726 | 0.003 |
21 | 14265353 | 0.002 |
11 | 17800024 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 12532403 | 23 |
0.005 | 4374813 | 26 |
0.006 | 5239567 | 10 |
0.007 | 1118334 | 6 |
0.008 | 332213 | 4 |
Last trade - 15.43pm 15/07/2024 (20 minute delay) ? |
Featured News
ECT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online